In the past decade, a new paradigm has emerged, EV translocation of functionally active EGFR and EGFR ligands between tumour cells and local and distant cells, imparting a quasi EGFR amplified phenotype upon the recipient cell [6] (Figure 1). Here, EGFR is linked to neoplasm.